-
1
-
-
45849105592
-
Stereoselective disposition of S- and R-Licarbazepine in mice
-
DOI 10.1002/chir.20546
-
Alves G, Figueiredo I, Falcão A, Castel-Branco M, Caramona M, Soares-da-Silva P,. (2008a) Stereoselective disposition of S- and R-Licarbazepine in mice. Chirality 20: 796-804. (Pubitemid 351961769)
-
(2008)
Chirality
, vol.20
, Issue.6
, pp. 796-804
-
-
Alves, G.1
Figueiredo, I.2
Falcao, A.3
Castel-Branco, M.4
Caramona, M.5
Soares-Da-Silva, P.6
-
2
-
-
52649131374
-
Disposition of eslicarbazepine acetate in the mouse after oral administration
-
Alves G, Figueiredo I, Castel-Branco M, Lourenço N, Falcão A, Caramona M, Soares-da-Silva P,. (2008b) Disposition of eslicarbazepine acetate in the mouse after oral administration. Fundam Clin Pharmacol 22: 529-536.
-
(2008)
Fundam Clin Pharmacol
, vol.22
, pp. 529-536
-
-
Alves, G.1
Figueiredo, I.2
Castel-Branco, M.3
Lourenço, N.4
Falcão, A.5
Caramona, M.6
Soares-Da-Silva, P.7
-
3
-
-
0030812306
-
Characterization of carbamazepine metabolism in a mouse model of carbamazepine teratogenicity
-
Amore B, Kalhorn T, Skiles G, Hunter A, Bennett G, Finnell R, Nelson S, Slattery J,. (1997) Characterization of carbamazepine metabolism in a mouse model of carbamazepine teratogenicity. Drug Metab Dispos 25: 953-962. (Pubitemid 27357693)
-
(1997)
Drug Metabolism and Disposition
, vol.25
, Issue.8
, pp. 953-962
-
-
Amore, B.M.1
Kalhorn, T.F.2
Skiles, G.L.3
Hunter, A.P.4
Bennett, G.D.5
Finnell, R.H.6
Nelson, S.D.7
Slattery, J.T.8
-
4
-
-
0033812631
-
In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil
-
Annaert P, Tukker J, Gelder J, Naesens L, Clercq E, Mooter G, Kinget R, Augustijns P,. (2000) In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil. J Pharm Sci 89: 1054-1062.
-
(2000)
J Pharm Sci
, vol.89
, pp. 1054-1062
-
-
Annaert, P.1
Tukker, J.2
Gelder, J.3
Naesens, L.4
Clercq, E.5
Mooter, G.6
Kinget, R.7
Augustijns, P.8
-
5
-
-
0347033287
-
Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: Focal cortical dysplasia and glioneuronal tumors
-
DOI 10.1016/S0306-4522(02)00992-2
-
Aronica E, Gorter JA, Jansen GH, van Veelen CW, van Rijen PC, Leenstra S, Ramkema M, Scheffer GL, Scheper RJ, Troost D,. (2003) Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience 118: 417-429. (Pubitemid 36423257)
-
(2003)
Neuroscience
, vol.118
, Issue.2
, pp. 417-429
-
-
Aronica, E.1
Gorter, J.A.2
Jansen, G.H.3
Van Veelen, C.W.M.4
Van Rijen, P.C.5
Leenstra, S.6
Ramkema, M.7
Scheffer, G.L.8
Scheper, R.J.9
Troost, D.10
-
6
-
-
79955067599
-
Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine
-
Bachmeier C, Beaulieu-Abdelahad D, Ganey N, Mullan M, Levin G,. (2011) Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine. Biopharm Drug Dispos 32: 233-244.
-
(2011)
Biopharm Drug Dispos
, vol.32
, pp. 233-244
-
-
Bachmeier, C.1
Beaulieu-Abdelahad, D.2
Ganey, N.3
Mullan, M.4
Levin, G.5
-
7
-
-
33846271368
-
Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein
-
DOI 10.1016/j.neuropharm.2006.07.038, PII S002839080600270X
-
Baltes S, Gastens A, Fedrowitz M, Potschka H, Kaever V, Löscher W,. (2007) Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacology 52: 333-346. (Pubitemid 46123353)
-
(2007)
Neuropharmacology
, vol.52
, Issue.2
, pp. 333-346
-
-
Baltes, S.1
Gastens, A.M.2
Fedrowitz, M.3
Potschka, H.4
Kaever, V.5
Loscher, W.6
-
8
-
-
74049163222
-
Key factors in the discovery and development of new antiepileptic drugs
-
Bialer M, White H,. (2010) Key factors in the discovery and development of new antiepileptic drugs. Nat Rev Drug Discov 9: 68-82.
-
(2010)
Nat Rev Drug Discov
, vol.9
, pp. 68-82
-
-
Bialer, M.1
White, H.2
-
9
-
-
0000312699
-
Physicochemical and drug-delivery considerations for oral drug bioavailability
-
DOI 10.1016/1359-6446(96)10039-8
-
Chan O, Stewart B,. (1996) Physicochemical and drug-delivery considerations for oral drug bioavailability. Drug Discov Today 1: 461-473. (Pubitemid 126393548)
-
(1996)
Drug Discovery Today
, vol.1
, Issue.11
, pp. 461-473
-
-
Chan, O.H.1
Stewart, B.H.2
-
10
-
-
44749090398
-
A novel design of artificial membrane for improving the PAMPA model
-
Chen X, Murawski A, Patel K, Crespi C, Balimane P,. (2008) A novel design of artificial membrane for improving the PAMPA model. Pharm Res 25: 1511-1520.
-
(2008)
Pharm Res
, vol.25
, pp. 1511-1520
-
-
Chen, X.1
Murawski, A.2
Patel, K.3
Crespi, C.4
Balimane, P.5
-
11
-
-
67049146675
-
A guide to Ussing chamber studies of mouse intestine
-
Clarke L,. (2009) A guide to Ussing chamber studies of mouse intestine. Am J Physiol Gastrointest Liver Physiol 296: G1151-G1166.
-
(2009)
Am J Physiol Gastrointest Liver Physiol
, vol.296
-
-
Clarke, L.1
-
12
-
-
58149164868
-
In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption
-
del Amo E, Heikkinen A, Mönkkönen J,. (2009) In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption. Eur J Pharm Sci 36: 200-211.
-
(2009)
Eur J Pharm Sci
, vol.36
, pp. 200-211
-
-
Del Amo, E.1
Heikkinen, A.2
Mönkkönen, J.3
-
13
-
-
40049110714
-
Carrier-mediated cellular uptake of pharmaceutical drugs: An exception or the rule?
-
DOI 10.1038/nrd2438, PII NRD2438
-
Dobson P, Kell D,. (2008) Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat Rev Drug Discov 7: 205-220. (Pubitemid 351321232)
-
(2008)
Nature Reviews Drug Discovery
, vol.7
, Issue.3
, pp. 205-220
-
-
Dobson, P.D.1
Kell, D.B.2
-
14
-
-
0036093847
-
The mucosa of the small intestine: How clinically relevant as an organ of drug metabolism?
-
Doherty M, Charman W,. (2002) The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism? Clin Pharmacokinet 41: 235-253. (Pubitemid 34533755)
-
(2002)
Clinical Pharmacokinetics
, vol.41
, Issue.4
, pp. 235-253
-
-
Doherty, M.M.1
Charman, W.N.2
-
15
-
-
77953806616
-
Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma
-
Fortuna A, Sousa J, Alves G, Falcão A, Soares-da-Silva P,. (2010) Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma. Anal Bioanal Chem 397: 1605-1615.
-
(2010)
Anal Bioanal Chem
, vol.397
, pp. 1605-1615
-
-
Fortuna, A.1
Sousa, J.2
Alves, G.3
Falcão, A.4
Soares-Da-Silva, P.5
-
16
-
-
84857558058
-
In vitro and in vivo relevance of the P-glycoprotein probe substrates in drug discovery and development: Focus on rhodamine 123, digoxin, and talinolol
-
Fortuna A, Alves G, Falcão A,. (2011) In vitro and in vivo relevance of the P-glycoprotein probe substrates in drug discovery and development: focus on rhodamine 123, digoxin, and talinolol. J Bioequiv Availab S2: 001-023.
-
(2011)
J Bioequiv Availab
, vol.2 S
, pp. 001-023
-
-
Fortuna, A.1
Alves, G.2
Falcão, A.3
-
17
-
-
77953359223
-
The effects of excipients on transporter mediated absorption
-
Goole J, Lindley D, Roth W, Carl S, Amighi K, Kauffmann J, Knipp G,. (2010) The effects of excipients on transporter mediated absorption. Int J Pharm 393: 17-31.
-
(2010)
Int J Pharm
, vol.393
, pp. 17-31
-
-
Goole, J.1
Lindley, D.2
Roth, W.3
Carl, S.4
Amighi, K.5
Kauffmann, J.6
Knipp, G.7
-
18
-
-
0035005884
-
Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine
-
DOI 10.1016/S0920-1211(01)00231-5, PII S0920121101002315
-
Hainzl D, Parada A, Soares-da-Silva P,. (2001) Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine. Epilepsy Res 44: 197-206. (Pubitemid 32452229)
-
(2001)
Epilepsy Research
, vol.44
, Issue.2-3
, pp. 197-206
-
-
Hainzl, D.1
Parada, A.2
Soares-Da-Silva, P.3
-
19
-
-
17844399522
-
Effects of pomegranate juice on human cytochrome P450 3A (CYP3A) and carbamazepine pharmacokinetics in rats
-
DOI 10.1124/dmd.104.002824
-
Hidaka M, Okumura M, Fujita K, Ogikubo T, Yamasaki K, Iwakiri T, Setoguchi N, Arimori K,. (2005) Effects of pomegranate juice on human cytochrome P450 3A (CYP3A) and carbamazepine pharmacokinetics in rats. Drug Metab Dispos 33: 644-648. (Pubitemid 40593878)
-
(2005)
Drug Metabolism and Disposition
, vol.33
, Issue.5
, pp. 644-648
-
-
Hidaka, M.1
Okumura, M.2
Fujita, K.-I.3
Ogikubo, T.4
Yamasaki, K.5
Iwakiri, T.6
Setoguchi, N.7
Arimori, K.8
-
20
-
-
24344439264
-
Transporters and drug therapy: Implications for drug disposition and disease
-
DOI 10.1016/j.clpt.2005.05.011, PII S0009923605002250
-
Ho R, Kim R,. (2005) Transporters and drug therapy: implications for drug disposition and disease. Clin Pharmacol Ther 78: 260-277. (Pubitemid 41254111)
-
(2005)
Clinical Pharmacology and Therapeutics
, vol.78
, Issue.3
, pp. 260-277
-
-
Ho, R.H.1
Kim, R.B.2
-
21
-
-
0347930741
-
Permeation prediction of M100240 using the parallel artificial membrane permeability assay
-
Hwang K, Martin N, Jiang J, Zhu C,. (2003) Permeation prediction of M100240 using the parallel artificial membrane permeability assay. J Pharm Pharm Sci 6: 315-320. (Pubitemid 38097544)
-
(2003)
Journal of Pharmacy and Pharmaceutical Sciences
, vol.6
, Issue.3
, pp. 315-320
-
-
Hwang, K.-K.1
Martin, N.E.2
Jiang, L.3
Zhu, C.4
-
22
-
-
77649216536
-
Membrane transporters in drug development
-
International Transporter Consortium.
-
International Transporter Consortium. (2010) Membrane transporters in drug development. Nat Rev Drug Discov 9: 215-236.
-
(2010)
Nat Rev Drug Discov
, vol.9
, pp. 215-236
-
-
-
23
-
-
34548203927
-
Comparative gene expression profiles of intestinal transporters in mice, rats and humans
-
DOI 10.1016/j.phrs.2007.06.005, PII S1043661807001260
-
Kim H, Park S, Cho H, Chae K, Sung J, Kim J, Landowski C, Sun D, El-Aty A, Amidon G, Shin H,. (2007) Comparative gene expression profiles of intestinal transporters in mice, rats and humans. Pharmacol Res 56: 224-236. (Pubitemid 47321206)
-
(2007)
Pharmacological Research
, vol.56
, Issue.3
, pp. 224-236
-
-
Kim, H.-R.1
Park, S.-W.2
Cho, H.-J.3
Chae, K.-A.4
Sung, J.-M.5
Kim, J.-S.6
Landowski, C.P.7
Sun, D.8
Abd El-Aty, A.M.9
Amidon, G.L.10
Shin, H.-C.11
-
24
-
-
51249095402
-
Use of the biopharmaceutical classification system in early drug development
-
Ku M,. (2008) Use of the biopharmaceutical classification system in early drug development. AAPS J 10: 208-212.
-
(2008)
AAPS J
, vol.10
, pp. 208-212
-
-
Ku, M.1
-
25
-
-
1442302325
-
Intestinal drug transporters: In vivo function and clinical importance
-
DOI 10.2174/1389200043489144
-
Kunta J, Sinko P,. (2004) Intestinal drug transporters: in vivo function and clinical importance. Curr Drug Metab 5: 109-124. (Pubitemid 38292004)
-
(2004)
Current Drug Metabolism
, vol.5
, Issue.1
, pp. 109-124
-
-
Kunta, J.R.1
Sinko, P.J.2
-
26
-
-
77954625557
-
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
-
Kwan P, Arzimanoglou A, Berg A, Brodie M, Hauser W, Mathern G, Moshé S, Perucca E, Wiebe S, French J,. (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51: 1069-1077.
-
(2010)
Epilepsia
, vol.51
, pp. 1069-1077
-
-
Kwan, P.1
Arzimanoglou, A.2
Berg, A.3
Brodie, M.4
Hauser, W.5
Mathern, G.6
Moshé, S.7
Perucca, E.8
Wiebe, S.9
French, J.10
-
27
-
-
35349012642
-
Animal data: The contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivo
-
DOI 10.1016/j.addr.2007.06.016, PII S0169409X07001706, Prediction of Therapeutic and Drug Delivery Outcomes Using Animal Models
-
Lennernäs H,. (2007) Animal data: the contributions of the Ussing chamber and perfusion systems to predicting human oral drug delivery in vivo. Adv Drug Deliv Rev 59: 1103-1120. (Pubitemid 47615203)
-
(2007)
Advanced Drug Delivery Reviews
, vol.59
, Issue.11
, pp. 1103-1120
-
-
Lennernas, H.1
-
28
-
-
38149073214
-
A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs
-
Linnet K, Ejsing T,. (2008) A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs. Eur Neuropsycopharmacol 18: 157-169.
-
(2008)
Eur Neuropsycopharmacol
, vol.18
, pp. 157-169
-
-
Linnet, K.1
Ejsing, T.2
-
29
-
-
67650215631
-
Third-generation antiepileptic drugs: Mechanisms of action, pharmacokinetics and interactions
-
Luszczki J,. (2009) Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions. Pharmacol Rep 61: 197-216.
-
(2009)
Pharmacol Rep
, vol.61
, pp. 197-216
-
-
Luszczki, J.1
-
30
-
-
77950479087
-
The anticonvulsants market
-
Mackey C,. (2010) The anticonvulsants market. Nat Rev Drug Discov 9: 265-266.
-
(2010)
Nat Rev Drug Discov
, vol.9
, pp. 265-266
-
-
MacKey, C.1
-
31
-
-
27244446035
-
A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy- 5H- dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine
-
DOI 10.1111/j.1528-1167.2005.00265.x
-
Marchi N, Guiso G, Rizzi M, Pirker S, Novak K, Czech T, Baumgartner C, Janigro D, Caccia S, Vezzani A,. (2005) A pilot study on brain-to-plasma partition of 10,11-Dyhydro-10- hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine. Epilepsia 46: 1613-1620. (Pubitemid 44921935)
-
(2005)
Epilepsia
, vol.46
, Issue.10
, pp. 1613-1620
-
-
Marchi, N.1
Guiso, G.2
Rizzi, M.3
Pirker, S.4
Novak, K.5
Czech, T.6
Baumgartner, C.7
Janigro, D.8
Caccia, S.9
Vezzani, A.10
-
32
-
-
0035724848
-
Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis
-
DOI 10.1016/S1056-8719(01)00161-7, PII S1056871901001617
-
Markowska M, Oberle R, Juzwin S, Hsu C, Gryszkiewicz M, Streeter A,. (2001) Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis. J Pharmacol Toxicol Methods 46: 51-55. (Pubitemid 34260896)
-
(2001)
Journal of Pharmacological and Toxicological Methods
, vol.46
, Issue.1
, pp. 51-55
-
-
Markowska, M.1
Oberle, R.2
Juzwin, S.3
Hsu, C.-P.4
Gryszkiewicz, M.5
Streeter, A.J.6
-
33
-
-
15244360297
-
The effect of Mdr1 induction on the pharmacokinetics of rhodamine 123 in rats
-
DOI 10.1111/j.1742-7843.2005.pto960322.x
-
Micuda S, Mundlova L, Mokry J, Osterreicher J, Cermanova J, Cizkova D, Martinkova J,. (2005) The effect of Mdr1 induction on the pharmacokinetics of rhodamine 123 in rats. Basic Clin Pharmacol Toxicol 96: 257-258. (Pubitemid 40388009)
-
(2005)
Basic and Clinical Pharmacology and Toxicology
, vol.96
, Issue.3
, pp. 257-258
-
-
Micuda, S.1
Mundlova, L.2
Mokry, J.3
Osterreicher, J.4
Cermanova, J.5
Cizkova, D.6
Martinkova, J.7
-
35
-
-
78349255907
-
Temporal trends in the mortality of people with epilepsy: A review
-
Neligan A, Bell G, Shorvon S, Sander J,. (2010) Temporal trends in the mortality of people with epilepsy: a review. Epilepsia 51: 2241-2246.
-
(2010)
Epilepsia
, vol.51
, pp. 2241-2246
-
-
Neligan, A.1
Bell, G.2
Shorvon, S.3
Sander, J.4
-
36
-
-
0036797498
-
The involvement of P-glycoprotein in berberine absorption
-
DOI 10.1034/j.1600-0773.2002.t01-1-910403.x
-
Pan G, Wang G-J, Liu X-D, Fawcett J, Xie Y-Y,. (2002) The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol 91: 193-197. (Pubitemid 35216922)
-
(2002)
Pharmacology and Toxicology
, vol.91
, Issue.4
, pp. 193-197
-
-
Pan, G.-Y.1
Wang, G.-J.2
Liu, X.-D.3
Fawcett, J.P.4
Xie, Y.-Y.5
-
37
-
-
77951034037
-
Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin
-
Pathak S, Udupa N,. (2010) Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin. Biopharm Drug Dispos 31: 202-214.
-
(2010)
Biopharm Drug Dispos
, vol.31
, pp. 202-214
-
-
Pathak, S.1
Udupa, N.2
-
38
-
-
34547828792
-
Development of new antiepileptic drugs: Challenges, incentives, and recent advances
-
DOI 10.1016/S1474-4422(07)70215-6, PII S1474442207702156
-
Perucca E, French J, Bialer M,. (2007) Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurol 6: 793-804. (Pubitemid 47243712)
-
(2007)
Lancet Neurology
, vol.6
, Issue.9
, pp. 793-804
-
-
Perucca, E.1
French, J.2
Bialer, M.3
-
39
-
-
72049119592
-
Targeting regulation of ABC efflux transporters in brain diseases: A novel therapeutic approach
-
Potschka H,. (2010) Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach. Pharmacol Ther 125: 118-127.
-
(2010)
Pharmacol Ther
, vol.125
, pp. 118-127
-
-
Potschka, H.1
-
40
-
-
0142148142
-
Evaluation of the blood-brain barrier transport, population pharmacokinetics, and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques
-
DOI 10.1124/jpet.103.053504
-
Raje S, Cao J, Newman A, Gao H, Eddington N,. (2003) Evaluation of the blood-brain barrier transport, population pharmacokinetics, and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques. J Pharmacol Exp Ther 307: 801-808. (Pubitemid 37310698)
-
(2003)
Journal of Pharmacology and Experimental Therapeutics
, vol.307
, Issue.2
, pp. 801-808
-
-
Raje, S.1
Cao, J.2
Newman, A.H.3
Gao, H.4
Eddington, N.D.5
-
41
-
-
33747049831
-
Diverse mechanisms of antiepileptic drugs in the development pipeline
-
DOI 10.1016/j.eplepsyres.2006.02.004, PII S0920121106000635
-
Rogawski M,. (2006) Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res 69: 273-294. (Pubitemid 44209049)
-
(2006)
Epilepsy Research
, vol.69
, Issue.3
, pp. 273-294
-
-
Rogawski, M.A.1
-
42
-
-
0038182033
-
Arbekacin is actively secreted in the rat intestine via a different efflux system from P-glycoprotein
-
DOI 10.1016/S0928-0987(03)00072-1
-
Saitoh H, Arashiki Y, Oka A, Oda M, Hatakeyama Y, Kobayashi M, Hosoi K,. (2003) Arbekacin is actively secreted in the rat intestine via a different efflux system from P-glycoprotein. Eur J Pharm Sci 19: 133-140. (Pubitemid 36668040)
-
(2003)
European Journal of Pharmaceutical Sciences
, vol.19
, Issue.2-3
, pp. 133-140
-
-
Saitoh, H.1
Arashiki, Y.2
Oka, A.3
Oda, M.4
Hatakeyama, Y.5
Kobayashi, M.6
Hosoi, K.7
-
43
-
-
77956631702
-
Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery
-
Sajeesh S, Vauthier C, Gueutin C, Ponchel G, Sharma C,. (2010) Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery. Acta Biomater 6: 3072-3080.
-
(2010)
Acta Biomater
, vol.6
, pp. 3072-3080
-
-
Sajeesh, S.1
Vauthier, C.2
Gueutin, C.3
Ponchel, G.4
Sharma, C.5
-
44
-
-
79953724893
-
Efficacy of new antiepileptic drugs
-
Schmidt D,. (2011a) Efficacy of new antiepileptic drugs. Epilepsy Curr 11: 9-11.
-
(2011)
Epilepsy Curr
, vol.11
, pp. 9-11
-
-
Schmidt, D.1
-
45
-
-
79961212342
-
Antiepileptic drug discovery: Does mechanism of action matter?
-
Schmidt D,. (2011b) Antiepileptic drug discovery: does mechanism of action matter? Epilepsy Behav 21: 342-343.
-
(2011)
Epilepsy Behav
, vol.21
, pp. 342-343
-
-
Schmidt, D.1
-
46
-
-
20544475805
-
Drug resistance in epilepsy: Putative neurobiologic and clinical mechanisms
-
DOI 10.1111/j.1528-1167.2005.54904.x
-
Schmidt D, Löscher W,. (2005) Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 46: 858-877. (Pubitemid 40847354)
-
(2005)
Epilepsia
, vol.46
, Issue.6
, pp. 858-877
-
-
Schmidt, D.1
Loscher, W.2
-
47
-
-
84455196058
-
The controversy over generic antiepileptic drugs
-
Shaw S, Hartman A,. (2010) The controversy over generic antiepileptic drugs. J Pediatr Pharmacol Ther 15: 81-93.
-
(2010)
J Pediatr Pharmacol Ther
, vol.15
, pp. 81-93
-
-
Shaw, S.1
Hartman, A.2
-
48
-
-
68149170038
-
The role of transporters in pharmacokinetics of orally administered drugs
-
Shugarts S, Benet L,. (2009) The role of transporters in pharmacokinetics of orally administered drugs. Pharm Res 26: 2039-2054.
-
(2009)
Pharm Res
, vol.26
, pp. 2039-2054
-
-
Shugarts, S.1
Benet, L.2
-
49
-
-
77953303004
-
Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay
-
Skolnik S, Lin X, Wang J, Chen X, He T, Zhang B,. (2010) Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay. J Pharm Sci. 99: 3246-3265.
-
(2010)
J Pharm Sci
, vol.99
, pp. 3246-3265
-
-
Skolnik, S.1
Lin, X.2
Wang, J.3
Chen, X.4
He, T.5
Zhang, B.6
-
50
-
-
79953682225
-
Development and validation of a fast isocratic liquid chromatography method for the simultaneous determination of norfloxacin, lomefloxacin and ciprofloxacin in human plasma
-
Sousa J, Alves G, Fortuna A, Pena A, Lino C, Falcão A,. (2011) Development and validation of a fast isocratic liquid chromatography method for the simultaneous determination of norfloxacin, lomefloxacin and ciprofloxacin in human plasma. Biomed Chromatogr 25: 535-541.
-
(2011)
Biomed Chromatogr
, vol.25
, pp. 535-541
-
-
Sousa, J.1
Alves, G.2
Fortuna, A.3
Pena, A.4
Lino, C.5
Falcão, A.6
-
51
-
-
0036246888
-
Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (-/-) mice
-
Stephens R, O'Neil C, Bennett J, Humphrey M, Henry B, Rowland M, Warhurst G,. (2002) Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (7/7) mice. Br J Pharmacol 135: 2038-2046. (Pubitemid 34478317)
-
(2002)
British Journal of Pharmacology
, vol.135
, Issue.8
, pp. 2038-2046
-
-
Stephens, R.H.1
O'Neill, C.A.2
Bennett, J.3
Humphrey, M.4
Henry, B.5
Rowland, M.6
Warhurst, G.7
-
52
-
-
0035977897
-
The importance of drug-transporting P-glycoproteins in toxicology
-
DOI 10.1016/S0378-4274(01)00304-6, PII S0378427401003046
-
Tellingen O,. (2001) The importance of drug transporting P-glycoproteins in toxicology. Toxicol Lett 120: 31-41. (Pubitemid 32375068)
-
(2001)
Toxicology Letters
, vol.120
, Issue.1-3
, pp. 31-41
-
-
Van Tellingen, O.1
-
53
-
-
67650591025
-
New findings on melatonin absorption and alterations by pharmaceutical excipients using the Ussing chamber technique with mounted rat gastrointestinal segments
-
Tran H, Tran P, Lee B,. (2009) New findings on melatonin absorption and alterations by pharmaceutical excipients using the Ussing chamber technique with mounted rat gastrointestinal segments. Int J Pharm 378: 9-16.
-
(2009)
Int J Pharm
, vol.378
, pp. 9-16
-
-
Tran, H.1
Tran, P.2
Lee, B.3
-
54
-
-
0033862088
-
Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines
-
DOI 10.1016/S0928-0987(00)00097-X, PII S092809870000097X
-
van der Sandt I, Blom-Roosemalen M, de Boer A, Breimer D,. (2000) Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines. Eur J Pharm Sci 11: 207-214. (Pubitemid 30616443)
-
(2000)
European Journal of Pharmaceutical Sciences
, vol.11
, Issue.3
, pp. 207-214
-
-
Van Der Sandt, I.1
Blom-Roosemalen, M.2
De Boer, A.3
Breimer, D.4
-
55
-
-
0035953319
-
Property-based design: Optimization of drug absorption and pharmacokinetics
-
DOI 10.1021/jm000407e
-
van De Waterbeemd H, Smith D, Beaumont K, Walker D,. (2001) Property-based design: optimization of drug absorption and pharmacokinetics. J Med Chem 44: 1313-1333. (Pubitemid 32852106)
-
(2001)
Journal of Medicinal Chemistry
, vol.44
, Issue.9
, pp. 1313-1333
-
-
Van De Waterbeemd, H.1
Smith, D.2
Beaumont, K.3
Walker, D.4
-
56
-
-
20744447950
-
Enhanced oral paclitaxel absorption with vitamin E-TPGS: Effect on solubility and permeability in vitro, in situ and in vivo
-
DOI 10.1016/j.ejps.2005.04.003, PII S0928098705001247
-
Varma M, Panchagnula R,. (2005) Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci 25: 445-453. (Pubitemid 40853872)
-
(2005)
European Journal of Pharmaceutical Sciences
, vol.25
, Issue.4-5
, pp. 445-453
-
-
Varma, M.V.S.1
Panchagnula, R.2
-
57
-
-
78649674647
-
Application of method suitability for drug permeability classification
-
Volpe D,. (2010) Application of method suitability for drug permeability classification. AAPS J 12: 670-678.
-
(2010)
AAPS J
, vol.12
, pp. 670-678
-
-
Volpe, D.1
-
58
-
-
0029836840
-
HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: In vitro-in vivo correlation with permeability data from rats and humans
-
DOI 10.1021/js960110x
-
Walter E, Janich S, Roessler B, Hilfinger J, Amidon G,. (1996) HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. J Pharm Sci 85: 1070-1076. (Pubitemid 26338920)
-
(1996)
Journal of Pharmaceutical Sciences
, vol.85
, Issue.10
, pp. 1070-1076
-
-
Walter, E.1
Janich, S.2
Roessler, B.J.3
Hilfinger, J.M.4
Amidon, G.L.5
-
59
-
-
4644327060
-
A possibility to predict the absorbability of poorly water-soluble drugs in humans based on rat intestinal permeability assessed by an in vitro chamber method
-
DOI 10.1016/j.ejpb.2004.03.029, PII S0939641104001109
-
Watanabe E, Takahashi M, Hayashi M,. (2004) A possibility to predict the absorbability of poorly water-soluble drugs in humans based on rat intestinal permeability assessed by an in vitro chamber method. Eur J Pharm Biopharm 58: 659-665. (Pubitemid 39297114)
-
(2004)
European Journal of Pharmaceutics and Biopharmaceutics
, vol.58
, Issue.3
, pp. 659-665
-
-
Watanabe, E.1
Takahashi, M.2
Hayashi, M.3
-
60
-
-
0141519420
-
Interaction of antiepileptic drugs with human P-glycoprotein in vitro
-
DOI 10.1124/jpet.103.054197
-
Weiss J, Kerpen C, Lindenmaier H, Dormann S-M, Haefeli W,. (2003) Interaction of antiepileptic drugs with human P-glycoprotein in vitro. J Pharmacol Exp Ther 307: 262-267. (Pubitemid 37151916)
-
(2003)
Journal of Pharmacology and Experimental Therapeutics
, vol.307
, Issue.1
, pp. 262-267
-
-
Weiss, J.1
Kerpen, C.J.2
Lindenmaier, H.3
Dormann, S.-M.G.4
Haefeli, W.E.5
-
61
-
-
33344454616
-
Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine
-
DOI 10.1016/j.jconrel.2005.11.011, PII S0168365905006541
-
Werle M, Hoffer M,. (2006) Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Release 111: 41-46. (Pubitemid 43289993)
-
(2006)
Journal of Controlled Release
, vol.111
, Issue.1-2
, pp. 41-46
-
-
Werle, M.1
Hoffer, M.2
-
62
-
-
33645314628
-
Ciprofloxacin permeability and its active secretion through rat small intestine in vitro
-
Zakelj S, Sturm K, Kristl A,. (2006) Ciprofloxacin permeability and its active secretion through rat small intestine in vitro. Int J Pharm 313: 175-180.
-
(2006)
Int J Pharm
, vol.313
, pp. 175-180
-
-
Zakelj, S.1
Sturm, K.2
Kristl, A.3
-
63
-
-
79958829984
-
Substrate- and species-dependent inhibition of P-glycoprotein-mediated transport: Implications for predicting in vivo drug interactions
-
Zolnerciks J, Booth-Genthe C, Gupta A, Harris J, Unadkat J,. (2011) Substrate- and species-dependent inhibition of P-glycoprotein-mediated transport: implications for predicting in vivo drug interactions. J Pharm Sci 100: 3055-3061.
-
(2011)
J Pharm Sci
, vol.100
, pp. 3055-3061
-
-
Zolnerciks, J.1
Booth-Genthe, C.2
Gupta, A.3
Harris, J.4
Unadkat, J.5
|